MedPath
HSA Approval

BRAVEX PAEDIATRIC SUSPENSION 100MG/5ML

SIN15828P

BRAVEX PAEDIATRIC SUSPENSION 100MG/5ML

BRAVEX PAEDIATRIC SUSPENSION 100MG/5ML

October 9, 2019

GOLDPLUS UNIVERSAL PTE LTD

GOLDPLUS UNIVERSAL PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantGOLDPLUS UNIVERSAL PTE LTD
Licence HolderGOLDPLUS UNIVERSAL PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

SUSPENSION

ORAL

Medical Information

M01AE01

ibuprofen

Manufacturer Information

GOLDPLUS UNIVERSAL PTE LTD

World Medicine Ilac Sanayi ve Ticaret A.S.

Active Ingredients

Ibuprofen

100mg/5ml

Ibuprofen

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

BRAVEX PAEDIATRIC SUSPENSION 100MG/5ML - HSA Approval | MedPath